Vascular endothelial growth factors with their receptors (VEGFC/A, VEGFR-1/3) have been characterized as essential lymphangiogenic factors, but research also showed their important role in angiogenesis and tumor progression via blood vessels [41,42,43]. This evidence concerns the gene FLT1 and neoplasm.